Cargando…

Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis

The angiotensin II type 1 receptor (AT1R) blocker losartan ameliorates rheumatoid arthritis (RA) in an experimental model. In RA, AT2R mainly opposes AT1R, but the mechanism by which this occurs still remains obscure. In the present study, we investigated the role of AT2R in the treatment of rats wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Di, Hu, Shanshan, Zhu, Jie, Yuan, Jun, Wu, Jingjing, Zhou, Aiwu, Wu, Yujing, Zhao, Wendi, Huang, Qiong, Chang, Yan, Wang, Qingtong, Sun, Wuyi, Wei, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Ltd 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914644/ https://www.ncbi.nlm.nih.gov/pubmed/24112447 http://dx.doi.org/10.1111/jcmm.12128

Ejemplares similares

Paroxetine alleviates T lymphocyte activation and infiltration to joints of collagen-induced arthritis
por: Wang, Qingtong, et al.
Publicado: (2017)

Effect of Losartan in Complete Freund’s Adjuvant –Induced Arthritis in Rats
por: Abdel El- Gaphar, Omnia Ahmed Mohamed, et al.
Publicado: (2018)

Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl(4)-Induced Skeletal Muscle Injury
por: Hwang, Ok-Kyung, et al.
Publicado: (2016)

Effect of Angiotensin II Type 1 Receptor Antagonist, Losartan on Inflammatory Factor in Atherosclerotic Rabbits
por: Xu, Yan-min, et al.
Publicado: (2013)

Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II/AGTR1 Signaling in Glioblastoma Cells
por: Panza, Salvatore, et al.
Publicado: (2021)

Losartan protects human stem cell-derived cardiomyocytes from angiotensin II-induced alcoholic cardiotoxicity
por: Song, Yuanxiu, et al.
Publicado: (2022)

Unveiling Angiotensin II and Losartan-Induced Gene Regulatory Networks Using Human Urine-Derived Podocytes
por: Thimm, Chantelle, et al.
Publicado: (2023)

Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer
por: Hashemzehi, Milad, et al.
Publicado: (2021)

Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells
por: GUO, YAN-SONG, et al.
Publicado: (2015)

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat
por: Yoshiji, Hitoshi, et al.
Publicado: (2009)

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects
por: Takagi, Hirotetsu, et al.
Publicado: (2021)

Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ(10), and angiotensin receptor blocker, losartan, on cardiovascular function
por: McLachlan, Jennifer, et al.
Publicado: (2014)

The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma
por: Coulson, Rhiannon, et al.
Publicado: (2017)

Losartan and isoproterenol promote alterations in the local renin-angiotensin system of rat salivary glands
por: Cano, Isadora Prado, et al.
Publicado: (2019)

Renin angiotensin system blockage by losartan neutralize hypercholesterolemia-induced inflammatory and oxidative injuries
por: AlSaad, Abdulaziz M.S., et al.
Publicado: (2020)

The effect of angiotensin 1-7 and losartan on renal ischemic/reperfusion injury in male rats
por: Safari, Tahereh, et al.
Publicado: (2019)

Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats
por: Failli, Paola, et al.
Publicado: (2009)

The therapeutic potential of losartan in lung metastasis of colorectal cancer
por: Hashemzehi, Milad, et al.
Publicado: (2020)

Therapeutic Effects of PADRE-BAFF Autovaccine on Rat Adjuvant Arthritis
por: Feng, Guo-dong, et al.
Publicado: (2014)

Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer
por: Zhao, Qing, et al.
Publicado: (2022)

Effects of Antihypertensive Agents on Intestinal Contractility in the Spontaneously Hypertensive Rat: Angiotensin Receptor System Downregulation by Losartan
por: Patten, Glen Stephen, et al.
Publicado: (2017)

Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model
por: Graus-Nunes, Francielle, et al.
Publicado: (2019)

Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKD
por: Wouda, Rosa D, et al.
Publicado: (2021)

Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease
por: Mao, Wei, et al.
Publicado: (2015)

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
por: Miao, Y., et al.
Publicado: (2010)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

A novel angiotensin II peptide vaccine without an adjuvant in mice
por: Nakamaru, Ryo, et al.
Publicado: (2021)

Identifications of potential therapeutic targets and drugs in angiotensin II-induced hypertension
por: Wu, Xiaoli, et al.
Publicado: (2017)

Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra
por: Grammatopoulos, Tom N, et al.
Publicado: (2007)

INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy—a Randomised Intervention Trial with losartan)
por: Olivotto, Iacopo, et al.
Publicado: (2015)

The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats
por: Siregar, Safendra, et al.
Publicado: (2023)

Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
por: Miao, Y., et al.
Publicado: (2011)

The Angiotensin Type 1 Receptor Antagonist Losartan Prevents Ovariectomy-Induced Cognitive Dysfunction and Anxiety-Like Behavior in Long Evans Rats
por: Campos, Glenda V., et al.
Publicado: (2019)

The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia
por: Wu, Liting, et al.
Publicado: (2021)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model
por: Ranjbar, Hoda, et al.
Publicado: (2018)

Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B
por: White, Zoe, et al.
Publicado: (2019)

Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: Possible involvement of angiotensin-converting enzyme-2
por: Han, Su-Xia, et al.
Publicado: (2010)

Regulating Th17/Treg Balance Contributes to the Therapeutic Effect of Ziyuglycoside I on Collagen-Induced Arthritis
por: Wang, Manman, et al.
Publicado: (2022)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_atcclh2buq29jppm8itbs07f44